| Literature DB >> 33410562 |
Cécile Saint-Martin1, Marine Cauchois-Le Mière2,3, Emily Rex4, Omar Soukarieh2, Jean-Baptiste Arnoux5, Julien Buratti1, Delphine Bouvet1, Thierry Frébourg2,3, Pascaline Gaildrat2, Show-Ling Shyng4, Christine Bellanné-Chantelot1, Alexandra Martins2.
Abstract
ABCC8 encodes the SUR1 subunit of the β-cell ATP-sensitive potassium channel whose loss of function causes congenital hyperinsulinism (CHI). Molecular diagnosis is critical for optimal management of CHI patients. Unfortunately, assessing the impact of ABCC8 variants on RNA splicing remains very challenging as this gene is poorly expressed in leukocytes. Here, we performed bioinformatics analysis and cell-based minigene assays to assess the impact on splicing of 13 ABCC8 variants identified in 20 CHI patients. Next, channel properties of SUR1 proteins expected to originate from minigene-detected in-frame splicing defects were analyzed after ectopic expression in COSm6 cells. Out of the analyzed variants, seven induced out-of-frame splicing defects and were therefore classified as recessive pathogenic, whereas two led to skipping of in-frame exons. Channel functional analysis of the latter demonstrated their pathogenicity. Interestingly, the common rs757110 SNP increased exon skipping in our system suggesting that it may act as a disease modifier factor. Our strategy allowed determining the pathogenicity of all selected ABCC8 variants, and CHI-inheritance pattern for 16 out of the 20 patients. This study highlights the value of combining RNA and protein functional approaches in variant interpretation and reveals the minigene splicing assay as a new tool for CHI molecular diagnostics.Entities:
Keywords: ABCC8; KATP channel SUR1 subunit; congenital hyperinsulinism; in silico predictions; minigene splicing assays; variants of unknown significance
Mesh:
Substances:
Year: 2021 PMID: 33410562 PMCID: PMC8049974 DOI: 10.1002/humu.24164
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878